Valeant: A Solid Price?

From Stocks To Watch Today
January 10, 2017 - 2:07pm

We noted earlier that Valeant Pharmaceuticals International (VRX) has popper today after selling assets for more than $2 billion, beginning what many expect to be just the first round of such sales. BMO's Gary Nachman notes that Valeant had received "a solid price" for its assets. He explains:

Continue reading this article »